Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 268276 |
| Drug Identification Number | 02439379 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP 2mg/mL, 100 mL BAG |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
| Packaging size | 100 mL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2025-10-01 |
| Estimated end date | 2025-12-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-18 |
| Company comments | Fresenius Kabi Canada regrets to advise that, due to an increase in demand, we will be encountering a supply interrup-tion on our Ropivacaine Hydrochloride Injection, USP 2 mg/mL, 100 mL Bag, effective October 1, 2025, until December 15, 2025. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-11-18 | English | Compare |
| v5 | 2025-10-03 | French | Compare |
| v4 | 2025-10-03 | English | Compare |
| v3 | 2025-10-01 | French | Compare |
| v2 | 2025-10-01 | English | Compare |
| v1 | 2025-10-01 | English | Compare |
Showing 1 to 6 of 6